Lupus nephritis: an overview of recent findings, Autoimmune Dis, vol.2012, pp.1-21, 2012. ,
The lupus autoantigens and the pathogenesis of systemic lupus erythematosus, Arthritis. Rheum. 1986, vol.29, issue.4, pp.457-460 ,
Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology, Adv. Immunol, vol.44, pp.93-151, 1989. ,
DOI : 10.1016/s0065-2776(08)60641-0
Anti-DNA antibodies bind directly to renal antigens and induce kidney dysfunction in the isolated perfused rat kidney, J. Immunol, vol.142, issue.9, pp.3076-3082, 1989. ,
Dissecting the immune cell mayhem that drives lupus pathogenesis, Sci. Transl. Med, vol.3, issue.73, pp.73-82, 2011. ,
Immunopathology of lupus nephritis, Semin. Immunopathol, vol.36, pp.443-459, 2014. ,
DOI : 10.1007/s00281-013-0413-5
From T to B and back again: positive feedback in systemic autoimmune disease, Nat. Rev. Immunol. 2001, vol.1, issue.2, pp.147-153 ,
T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression, Mol. Cell Biol, vol.7, issue.12, p.4472, 1987. ,
Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state, Int. Immunol, vol.10, issue.12, pp.1969-1980, 1998. ,
DOI : 10.1093/intimm/10.12.1969
URL : https://academic.oup.com/intimm/article-pdf/10/12/1969/18316501/101969.pdf
CTLA-4 control over Foxp3+ regulatory T cell function, Science, vol.322, issue.5899, pp.271-275, 2008. ,
DOI : 10.1126/science.1160062
Systemic lupus erythematosus: a therapeutic challenge for the XXI century, Clin. Rheumatol, vol.33, issue.4, pp.441-450, 2014. ,
Lupus nephritis: review of the literature, Curr. Allergy Asthma Rep. 2013, vol.13, issue.6, pp.580-586 ,
Post hoc analysis of the phase II/III APRIL-SLE study: association between response to atacicept and serum biomarkers including BLyS and APRIL: post hoc analysis of the April-SLE study. Arthritis Rheumatol, vol.69, pp.122-130, 2017. ,
Efficacy and safety of an interleukin 6 monoclonal, Eur. J. Immunol, vol.47, pp.1368-1376, 2017. ,
, antibody for the treatment of systemic lupus erythematosus: a phase II dose-ranging randomised controlled trial, Ann. Rheum. Dis, vol.76, pp.534-542, 2016.
The short-term efficacy of bortezomib combined with glucocorticoids for the treatment of refractory lupus nephritis, 2017. ,
Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse, J. Exp. Med, vol.181, issue.3, pp.1145-1155, 1995. ,
Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE, Immunity, vol.3, issue.6, pp.739-745, 1995. ,
Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation, J. Clin. Invest, vol.95, issue.6, pp.2783-2789, 1995. ,
B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy, Cell, vol.80, issue.5, pp.707-718, 1995. ,
DOI : 10.1016/0092-8674(95)90349-6
URL : https://doi.org/10.1016/0092-8674(95)90349-6
Cutting edge: reversal of murine lupus nephritis with CTLA4Ig and cyclophosphamide, J. Immunol. Baltim. Md, vol.166, issue.5, pp.2913-2916, 1950. ,
Treatment of murine lupus with CTLA4Ig, Science, vol.265, issue.5176, pp.1225-1227, 1994. ,
gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory, J. Exp. Med. 1994, vol.180, issue.1, pp.157-163 ,
CTLA4Ig inhibits T cell-dependent B-cell maturation in murine systemic lupus erythematosus, J. Clin. Invest, vol.106, issue.1, pp.91-101, 2000. ,
The differentiation of human memory B cells into specific antibody-secreting cells is CD40 independent, Eur J Immunol. mars, vol.26, issue.3, pp.517-524, 1996. ,
Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE, Immunity, vol.3, issue.6, pp.739-745, 1995. ,
Inducing CTLA-4-dependent immune regulation by selective CD28 blockade promotes regulatory T cells in organ transplantation ,
, Sci. Transl. Med. 2010, vol.2, issue.17, pp.17-27
Selective CD28 blockade attenuates acute and chronic rejection of murine cardiac allografts in a CTLA-4-dependent manner ,
, Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transpl. Surg. 2011, vol.11, issue.8, pp.1599-609
2B4 (CD244) induced by selective CD28 blockade functionally regulates allograft-specific CD8+ T cell responses ,
, J. Exp. Med. 2014, vol.211, issue.2, pp.297-311
PD-1-dependent mechanisms maintain peripheral tolerance of donor-reactive CD8+ T cells to transplanted tissue, J. Immunol, vol.181, pp.5313-5322, 2008. ,
Molecular mechanisms of T cell co-stimulation and co-inhibition, Nat. Rev. Immunol. 2013, vol.13, issue.4, pp.227-242 ,
Increased Foxp3+ CD4+ regulatory T cells with intact suppressive activity but altered cellular localization in murine lupus, Am. J. Pathol, vol.173, issue.6, pp.1682-1692, 2008. ,
, Abbreviations: SLE: Systemic Lupus Erythematosus · Ds DNA: double stranded DNA · Ags: antigens · Abs: antibodies · AutoAbs: Autoantibodies · Tregs: regulatory T cells · TCR: T Cell Receptor · PD-1: Programmed Cell Death -1 · PDL-1: Programmed Death Ligand -1 · IDO: Indoleamine 2, 3 DiOxygenase Full correspondence: Prof. Fadi Fakhouri, pp.33-2400084660
, Fadi.Fakhouri@univ-nantes.fr